Search

Your search keyword '"Michel Zummer"' showing total 84 results

Search Constraints

Start Over You searched for: Author "Michel Zummer" Remove constraint Author: "Michel Zummer"
84 results on '"Michel Zummer"'

Search Results

1. Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis

2. Evaluating a new referral pathway from physical therapists to rheumatologists: A qualitative study

3. Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients With Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations

4. Do physical therapists follow evidence-based practices for treatment of inflammatory arthritis? Results from an online survey

5. First Biologic Drug Persistence in Patients With Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

6. Rheumatologists’ Acceptance of Patient Referrals from Physical Therapists

7. Development of a Patient-centered Quality Measurement Framework for Measuring, Monitoring, and Optimizing Rheumatoid Arthritis Care in Canada

8. A comparison between childhood and adult onset systemic lupus erythematosus adjusted for ethnicity from the 1000 Canadian Faces of Lupus Cohort

9. A Bridge Too Far? Real-World Practice Patterns of Early Glucocorticoid Use in the Canadian Early Arthritis Cohort

10. Persistent Disease Activity Remains a Burden for Patients with Systemic Lupus Erythematosus

11. Stand Up and Be Counted: Measuring and Mapping the Rheumatology Workforce in Canada

12. Review of Current Workforce for Rheumatology in the Countries of the Americas 2012–2015

13. SAT0393 EFFECTIVENESS AND SAFETY OF INFLIXIMAB, GOLIMUMAB AND USTEKINUMAB IN PSORIATIC ARTHRITIS PATIENTS FROM A PROSPECTIVE OBSERVATIONAL REGISTRY

14. Physical Therapists' Ability to Distinguish Between Inflammatory and Noninflammatory Arthritis and to Appropriately Refer Patients to a Rheumatologist

15. Influence of Education on Disease Activity and Damage in Systemic Lupus Erythematosus: Data From the 1000 Canadian Faces of Lupus

16. Planning for the Rheumatologist Workforce: Factors Associated With Work Hours and Volumes

17. Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort

18. Development of a Canadian Core Clinical Dataset to Support High-quality Care for Canadian Patients with Rheumatoid Arthritis

19. Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice

20. Does Socioeconomic Status Affect Outcomes in Early Inflammatory Arthritis? Data from a Canadian Multisite Suspected Rheumatoid Arthritis Inception Cohort

21. Cancer Risk Factors in SLE: Multivariate Regression Analysis in 16,409 Patients

22. Earlier Time to Remission Predicts Sustained Clinical Remission in Early Rheumatoid Arthritis — Results from the Canadian Early Arthritis Cohort (CATCH)

23. Association of Smoking With Cutaneous Manifestations in Systemic Lupus Erythematosus

24. Influence of Education on Disease Activity and Damage in Systemic Lupus Erythematosus: Data From the 1000 Canadian Faces of Lupus

25. Canadian Recommendations for Clinical Trials of Pharmacologic Interventions in Rheumatoid Arthritis: Inclusion Criteria and Study Design: Table 1

26. The Spondyloarthritis Research Consortium of Canada Registry for Spondyloarthritis

27. A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles

28. Optimal care for rheumatoid arthritis: a focus group study

29. Clinical and Serologic Factors Associated with Lupus Pleuritis

30. Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates

31. Determinants of sleep problems in patients with spondyloarthropathy

32. The 1000 Canadian Faces of Lupus: Determinants of Disease Outcome in a Large Multiethnic Cohort

33. Evaluation of the clinimetric properties of the Early Inflammatory Arthritis--self-administered comorbidity questionnaire

34. Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI

35. Development of System-level Performance Measures for Evaluation of Models of Care for Inflammatory Arthritis in Canada

36. Predicting Low Disease State and Remission in Early Rheumatoid Arthritis in the First Six Months, Comparing the Simplified Disease Activity Index and European League Against Rheumatism Response Measures: Results From an Early Arthritis Cohort

37. Mortality related to cerebrovascular disease in systemic lupus erythematosus

38. An international cohort study of cancer in systemic lupus erythematosus

39. Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registry

40. Effect of age at menopause on disease presentation in early rheumatoid arthritis: results from the Canadian Early Arthritis Cohort

41. The frequency of and associations with hospitalization secondary to lupus flares from the 1000 Faces of Lupus Canadian cohort

42. AB0684 Gender Specific Differences in Ankylosing Spondylitis at Treatment Initiation in Patients Treated with Infliximab or Golimumab: Table 1

43. AB0661 Predictors of Response in Patients with Ankylosing Spondylitis Treated with Infliximab or Golimumab in A Real-World Setting

44. FRI0421 What Is The Location of Enthesitis in Ankylosing Spondylitis and Psoriatic Arthritis Patients and How Do They Respond To Anti-TNF Treatment?: Table 1

45. FRI0473 What Proportion of Patients with PSA Fail To Achieve Mda Based on Patient Reported Outcomes? An Analysis from A Prospective, Observational Registry

46. FRI0467 Predictors of Early Minimal Disease Activity in PSA Patients Treated with Anti-TNF in A Real-World Registry

47. Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis

48. Cancer risk in systemic lupus: an updated international multi-centre cohort study

49. Increasing treatment in early rheumatoid arthritis is not determined by the disease activity score but by physician global assessment: results from the CATCH study

50. Psoriatic arthritis in Canadian clinical practice: the PsA assessment in rheumatology

Catalog

Books, media, physical & digital resources